Is Auro Laboratories Ltd debt-free?

No, Auro Laboratories Ltd is not debt-free with a debt-to-equity ratio of 1.05.

Home

Auro Laboratories Ltd

Auro Laboratories Ltd Financials

Auro Laboratories Ltd Financial Statement

Auro Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	7.53	3.20	3.41
Operating Expense	6.59	2.61	2.38
Net Profit	0.39	0.05	0.36
Net Profit Margin	5.18	1.56	10.56
Earning Per Share	0.63	0.08	0.57
EBIDTA	1	0.59	1.03
Effective Tax Rate	2.13	3.45	11.65

Particulars	Mar 2025
Revenue	7.53
Operating Expense	6.59
Net Profit	0.39
Net Profit Margin	5.18
Earning Per Share	0.63
EBIDTA	1.00
Effective Tax Rate	2.13

Auro Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	53.64	52.89	50.87
Operating Expenses Annual	42.97	48.50	46.24
Operating Profit Annual	12.17	5.33	5.72
Interest Annual	0.74	0.81	0.83
Depreciation	1.09	1.07	1.02
Net Profit Annual	7.79	2.44	2.84
Tax Annual	2.55	1.00	1.03

Particulars	Mar 2024
Total Revenue Annual	53.64
Operating Expenses Annual	42.97
Operating Profit Annual	12.17
Interest Annual	0.74
Depreciation	1.09
Net Profit Annual	7.79
Tax Annual	2.55

Auro Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	2.42	12.40	14.54
Cash Flow from Operations	18.81	3.28	-6.59
Cash Flow from Investing	-38.67	-5.08	-5.34
Cash Flow from Financing	19.09	-8.18	9.79
Cash Flow at the End	1.65	2.42	12.40

Particulars	Mar 2024
Cash Flow at the Beginning	2.42
Cash Flow from Operations	18.81
Cash Flow from Investing	-38.67
Cash Flow from Financing	19.09
Cash Flow at the End	1.65

Auro Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	22.71	10.08	11.24
PBIT Margin (%)	20.67	8.05	9.24
PBT Margin (%)	-7.24	-1.88	-1.89
Net PROFIT Margin (%)	14.52	4.61	5.58
Return On Networth / Equity (%)	20.46	7.43	9.45
Return On Networth /Employed (%)	20.37	9.89	12.20
Return On Assets (%)	14.38	5.67	7.37
Total Debt / Equity (X)	0.43	0.31	0.28
Asset Turnover Ratio (%)	0.99	1.23	1.32

Particulars	Mar 2024
PBDIT Margin (%)	22.71
PBIT Margin (%)	20.67
PBT Margin (%)	-7.24
Net PROFIT Margin (%)	14.52
Return On Networth / Equity (%)	20.46
Return On Networth /Employed (%)	20.37
Return On Assets (%)	14.38
Total Debt / Equity (X)	0.43
Asset Turnover Ratio (%)	0.99

Auro Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	22.15	12.62	13.61
Total Current Assets Annual	30.85	35.66	37.63
Non Current Assets Annual	54.88	20.33	17.33
Total Shareholders Funds Annual	41.96	34.20	31.52
Total Assets Annual	85.73	55.99	54.96

Particulars	Mar 2024
Fixed Assets Annual	22.15
Total Current Assets Annual	30.85
Non Current Assets Annual	54.88
Total Shareholders Funds Annual	41.96
Total Assets Annual	85.73

Auro Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Auro Laboratories Ltd Financials

As of Jun 29, 2025, Auro Laboratories Ltd has a market capitalization of 143.69 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Auro Laboratories Ltd is not with a debt-to-equity ratio of 1.05.

In FY 2024 , Auro Laboratories Ltd recorded a total revenue of approximately 19.40 Cr marking a significant milestone in the company's financial performance.

Auro Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and -0.5% annually, respectively..

Auro Laboratories Ltd's current PE ratio is 78.09.

Auro Laboratories Ltd's ROCE averaged 10.0% from the FY ending March 2023 to 2025, with a median of 10.5%. It peaked at 16.2% in March 2024, reflecting strong capital efficiency over the period..

Auro Laboratories Ltd's latest EBIT is Rs. 2.96 Cr, surpassing the average EBIT of Rs. 6.10 Cr over the 5 years..